Evidence map›Paper›PMID 32778112›Full record

ArticleMicrobial cell factories2020

Efficient 2,3-butanediol production from whey powder using metabolically engineered Klebsiella oxytoca.

Wensi Meng, Yongjia Zhang, Menghao Cao, Wen Zhang, Chuanjuan Lü, Chunyu Yang, Chao Gao, Ping Xu, Cuiqing Ma

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 37 citations in OpenAlex.

  1. Multistep metabolic engineeredSynthetic and systems biotechnology · 2026
    Article
  2. Review
  3. Review
  4. Mixed Culture Cultivation in Microbial Bioprocesses.Advances in biochemical engineering/biotechnology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wensi MengState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China.
Yongjia ZhangState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China.
Menghao CaoState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China.
Wen ZhangCenter for Gene and Immunotherapy, The Second Hospital of Shandong University, Jinan, 250033, People's Republic of China.
Chuanjuan LüState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China. chuanjuanlv@mail.sdu.edu.cn.
Chunyu YangState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China.
Chao GaoState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China.
Ping XuState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, and School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, People's Republic of China.
Cuiqing MaState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, People's Republic of China. macq@sdu.edu.cn.ORCID http://orcid.org/0000-0002-7468-1027
Shandong University · CNSecond Hospital of Shandong University · CNShanghai Jiao Tong University · CN

Funding

Key R&D Program of Shandong Provincial 2019GSF107034Key R&D Program of Shandong Provincial 2019GSF107039National Key R&D Program of China 2019YFA0904803National Key R&D Program of China 2019YFA0904900National Natural Science Foundation of China 31670041Natural Science Foundation of Shandong Provincial ZR2018PC008Shandong Provincial Funds for Distinguished Young Scientists JQ 201806
6 · The paper itself

Abstract

backgroundWhey is a major pollutant generated by the dairy industry. To decrease environmental pollution caused by the industrial release of whey, new prospects for its utilization need to be urgently explored. Here, we investigated the possibility of using whey powder to produce 2,3-butanediol (BDO), an important platform chemical.

resultsKlebsiella oxytoca strain PDL-0 was selected because of its ability to efficiently produce BDO from lactose, the major fermentable sugar in whey. After deleting genes pox, pta, frdA, ldhD, and pflB responding for the production of by-products acetate, succinate, lactate, and formate, a recombinant strain K. oxytoca PDL-K5 was constructed. Fed-batch fermentation using K. oxytoca PDL-K5 produced 74.9 g/L BDO with a productivity of 2.27 g/L/h and a yield of 0.43 g/g from lactose. In addition, when whey powder was used as the substrate, 65.5 g/L BDO was produced within 24 h with a productivity of 2.73 g/L/h and a yield of 0.44 g/g.

conclusionThis study demonstrated the efficiency of K. oxytoca PDL-0 for BDO production from whey. Due to its non-pathogenicity and efficient lactose utilization, K. oxytoca PDL-0 might also be used in the production of other important chemicals using whey as the substrate.

Indexed as

Batch Cell Culture TechniquesBioreactorsButylene GlycolsFermentationGene Knockout TechniquesKlebsiella oxytocaMetabolic EngineeringPowdersWhey2,3-butylene glycolButylene GlycolsPowders2,3-ButanediolKlebsiella oxytoca PDL-0LactoseMetabolic engineeringWhey

Identifiers

PMID32778112
PMCPMC7419187
OpenAlexW3048484676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.